| Literature DB >> 23190709 |
Bouh Abdi Khaireh1, Sébastien Briolant, Aurélie Pascual, Madjid Mokrane, Vanessa Machault, Christelle Travaillé, Mohamed Abdi Khaireh, Ismail Hassan Farah, Habib Moussa Ali, Abdul-Ilah Ahmed Abdi, Souleiman Nour Ayeh, Houssein Youssouf Darar, Lénaïck Ollivier, Mohamed Killeh Waiss, Hervé Bogreau, Christophe Rogier, Bruno Pradines.
Abstract
BACKGROUND: Formerly known as a hypoendemic malaria country, the Republic of Djibouti declared the goal of pre-eliminating malaria in 2006. The aim of the present study was to evaluate the prevalence of Plasmodium falciparum, Plasmodium vivax and mixed infections in the Djiboutian population by using serological tools and to identify potential determinants of the disease and hotspots of malaria transmission within the country.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23190709 PMCID: PMC3544601 DOI: 10.1186/1475-2875-11-395
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Multivariate logistic regression analysis of . infection’s seroprevalence
| Male | 742 | 256 | 34.5 (31.1-38.0) | 1 | 1 | 0.0008 |
| Female | 1168 | 346 | 29.6 (27.0-32.3) | 0.78 (0.63-0.96) | 0.68 (0.55 - 0.85) | |
| No school | 1244 | 448 | 36.0 (33.3-38.6) | 1 | 1 | 0.033 |
| Primary | 410 | 106 | 25.9 (21.7-30.4) | 0.65 (0.50-0.84) | 0.66(0.50 - 0.87) | 1.6x10-5 |
| Secondary, high school or University | 256 | 48 | 18.8 (14.2-24.1) | 0.45 (0.32-0.64) | 0.45 (0.31 - 0.64) | |
| Yes | 167 | 70 | 41.9 (34.3-49.8) | 1 | 1 | 0.0005 |
| No | 1743 | 532 | 30.5 (28.4-32.7) | 0.50 (0.35-0.72) | 0.52 (0.36 - 0.75) | |
| Yes | 435 | 175 | 40.2 (35.6-45.0) | 1 | 1 | 0.0003 |
| No | 1475 | 427 | 28.9 (26.8-31.5) | 0.61 (0.47-0.78) | 0.63 (0.49 - 0.81) | |
| [15–40] | 1360 | 401 | 29.5 (27.1-32.0) | 1 | 1 | 0.0346 |
| [40–55] | 550 | 201 | 36.5 (32.5-40.7) | 1.42 (1.14-1.77) | 1.28 (1.02 - 1.61) | |
| > 1.5 Km | 1279 | 364 | 28.5 (26.0-31.0) | 1 | 1 | 0.0671 |
| ≤ 1.5 Km | 631 | 238 | 37.7 (33.9-41.6) | 1.48 (0.99-2.21) | 1.44 (0.97 - 2.14) | |
N = number; P = seropositivity to P. falciparum; RE = Random effect; cOR = Crude Odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
Multivariate logistic regression analysis of . infection’s seroprevalence
| | | | | | | |
| Male | 742 | 147 | 19.8 (17.0-22.9) | 1 | 1 | |
| Female | 1168 | 187 | 16.0 (14.0-18.2) | 0.75 (0.59-0.97) | 0.72 (0.56-0.93) | 0.0106 |
| | | | | | | |
| Schooled | 666 | 97 | 14.6 (10.6-15.9) | 1 | 1 | |
| Never schooled | 1244 | 237 | 19.1 (16.9-21.3) | 1.32 (1.01-1.73) | 1.40 (1.06-1.85) | 0.0163 |
| | | | | | | |
| Yes | 167 | 45 | 26.9 (20.4-34.3) | 1 | 1 | |
| No | 1743 | 289 | 16.6 (14.9-18.4) | 0.51 (0.34-0.75) | 0.52 (0.35-0.77) | 0.0012 |
N = number; P = seropositivity to P. vivax; RE = Random effect; cOR = Crude odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
Multivariate logistic regression analysis of . and mixed infection’s seroprevalence
| Rural | 553 | 43 | 7.8 (5.7-10.3) | 1 | 1 | 0.0477 |
| Urban | 1357 | 152 | 11.2 (9.6-13.0) | 1.52 (0.83-2.78) | 1.77 (1.01 - 3.11) | |
| Male | 742 | 91 | 12.3 (10.0-14.8) | 1 | 1 | 0.0006 |
| Female | 1168 | 104 | 8.9 (7.3-10.7) | 0.65 (0.47-0.90) | 0.56 (0.40 - 0.78) | |
| Schooled | 666 | 44 | 6.6 (4.8-8.8) | 1 | 1 | 0.004 |
| Never Schooled | 1244 | 151 | 12.1 (10.4-14.1) | 1.81 (1.24-2.63) | 2.04 (1.38 - 3.02) | |
| Yes | 167 | 31 | 18.6 (13.0-25.3) | 1 | 1 | 0.0012 |
| No | 1743 | 164 | 9.4 (8.1-10.9) | 0.39 (0.24-0.64) | 0.45 (0.27 - 0.73) | |
| Yes | 435 | 65 | 14.9 (11.7-18.6) | 1 | 1 | 0.0011 |
| No | 1475 | 130 | 8.8 (7.4-10.4) | 0.54 (0.37-0.77) | 0.54 (0.38 - 0.78) | |
| > 1.5 Km | 1210 | 97 | 8.0 (6.5-9.7) | 1 | 1 | 0.0190 |
| ≤ 1.5 Km | 700 | 98 | 14.0 (11.5-16.8) | 1.83 (1.07-3.13) | 1.83 (1.10 - 3.04) | |
N = number; P = seropositivity to P. falciparum and P. vivax; RE = Random effect; cOR = Crude Odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
Figure 1Proportions of . and . seropositives to the different peptides and recombinant proteins from the different L-groups (for , L0 = seronegativity MFI < 1000, L1 = 1000 ≤ MFI < 3800, L2 = 3800 ≤ MFI < 8000, and L3 = MFI ≥ 8000; for . L0 = seronegativity MFI < 1000, L1 = 1000 ≤ MFI < 2000, L2 = 2000 ≤ MFI < 10000 and L3 = MFI ≥ 10000).
Figure 2Distribution of corrected MFI values against the . antigens in the L1, L2 and L3 groups.
Multivariate ordinal logistic regression analysis of serological response to . antigens
| Male | 742 | 80 | 79 | 97 | 256 | 1 | 1 | 0.0008 |
| Female | 1168 | 116 | 127 | 103 | 346 | 0.78 (0.65-0.95) | 0.66 (0.54-0.81) | |
| No school | 1244 | 141 | 145 | 162 | 448 | 1 | 1 | |
| Primary | 410 | 40 | 39 | 27 | 106 | 0.61 (0.47-0.77) | 0.60 (0.47-0.77) | |
| Secondary, high school or University | 256 | 15 | 22 | 11 | 48 | 0.41 (0.30-0.57) | 0.39 (0.28-0.55) | |
| | | | | | | | | |
| Yes | 167 | 19 | 18 | 33 | 70 | 1 | 1 | 0.0019 |
| No | 1743 | 177 | 188 | 167 | 532 | 0.57 (0.42-0.78) | 0.55 (0.40-0.76) | |
| | | | | | | | | |
| Yes | 435 | 48 | 58 | 69 | 175 | 1 | 1 | 0.0002 |
| No | 1475 | 148 | 148 | 131 | 427 | 0.59 (0.47-0.72) | 0.59 (0.47-0.73) | |
| | | | | | | | | |
| > 1.5 Km | 1210 | 124 | 121 | 101 | 346 | 1 | 1 | 0.0007 |
| ≤ 1.5 Km | 700 | 72 | 85 | 99 | 256 | 1.49 (1.23-1.81) | 1.53 (1.25-1.87) | |
| Often to Always | 769 | 82 | 90 | 107 | 279 | 1 | 1 | 0.0007 |
| Rarely to Never | 1141 | 114 | 116 | 93 | 323 | 0.67 (0.56-0.81) | 0.61 (0.50-0.74) | |
N = number; P = seropositivity to P. falciparum; L = level of intensity of immunological response (seropositivity to P. falciparum antigens) measured in MFI with 3 levels: 1, 2, 3 corresponding respectively to 1000 ≤ MFI < 3800, 3800 ≤ MFI < 8000, MFI ≥ 8000. The level L0 is not shown here as it’s corresponding to value of MFI < 1000 considered as negative reaction. RE = Random effect; cOR = Crude Odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
Figure 3Distribution of corrected MFI values against the antigens in the L1, L2 and L3 groups.
Multivariate ordinal logistic regression analysis of the serological response to . antigens
| Male | 742 | 51 | 52 | 44 | 147 | 1 | 1 | 0.0286 |
| Female | 1168 | 54 | 65 | 68 | 187 | 0.79 (0.62-1.00) | 0.74 (0.58-0.94) | |
| Schooled | 666 | 37 | 35 | 25 | 97 | 1 | 1 | 0.0168 |
| Non Schooled | 1244 | 68 | 82 | 87 | 237 | 1.41 (1.09-1.82) | 1.44 (1.11-1.87) | |
| Yes | 167 | 9 | 18 | 18 | 45 | 1 | 1 | 0.0042 |
| No | 1743 | 96 | 99 | 94 | 289 | 0.52 (0.37-0.75) | 0.53 (0.37-0.76) | |
| Yes | 435 | 25 | 29 | 36 | 90 | 1 | 1 | 0.0447 |
| No | 1475 | 80 | 88 | 76 | 244 | 0.75 (0.57-0.97) | 0.74 (0.56-0.97) | |
| > 1.5 Km | 1210 | 66 | 65 | 60 | 191 | 1 | 1 | 0.0301 |
| ≤ 1.5 Km | 700 | 39 | 52 | 52 | 143 | 1.39 (1.09-1.76) | 1.35 (0.56-0.97) | |
N = number; P = seropositivity to P. vivax; L = level of intensity of immunological response (seropositivity to P. vivax antigens) measured in MFI with 3 levels: 1, 2, 3 corresponding respectively to 1000 ≤ MFI < 2000, 2000 ≤ MFI < 10000 and MFI ≥ 10000. The level L0 is not shown here as it’s corresponding to value of MFI < 1000 considered as negative reaction. RE = Random effect; cOR = Crude Odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
Figure 4Map of clusters of seroprevalence in the capital of the republic of Djibouti.
Figure 5Map of clusters of seroprevalence in the republic of Djibouti.
Figure 6Map of clusters of seroprevalence in the capital of the republic of Djibouti.
Figure 7Map of clusters of seroprevalence in the republic of Djibouti.